News

Keep up to date with our latest announcements.

December 5, 2024
New

Interna Therapeutics Reports on an Ongoing Phase I Clinical Trial of an Intranasal COVID-19 Drug

Interna Therapeutics will be attending the J.P. Morgan 43rd Annual Healthcare Conference on January 13-16, 2025, in San Francisco, CA, USA

Interna Therapeutics announces that it will present at the upcoming Investival Showcase conference on November 18, 2024, in London, UK

November 4, 2024

Aposense Ltd. Secures $10.25 Million Funding Round; Announces Merger with SirVir and name change to “Interna Therapeutics”

Aposense gives a short talk at the Delivery of Nucleic Acid Therapeutics II: Biology, Engineering and Development conference in Siracusa, Sicily, Italy, Apr 4-8, 2024